(S)-3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid, 95.0%, 250mg

5,5,5-Trifluoro-2,4-dioxopentanoic acid ethyl ester, 95.0%, 25g

4,5,6,7-Tetrahydro-2H-indazol-3-amine, 95.0%, 500mg

Oxion Inverso OX.2253-PLPHF mit LWD Plan Fluarex 10x und Plan Phase Fluarex 20x/40x Objektiven, 2-Positionen-Filterblöcken und XY-Kreuztisch

4-Aminobenzophenone>98.0%(GC)(T)5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98%, 1g

4,4',4''-((1,3,5-TRIAZINE-2,4,6-TRIYL)TRIS(OXY))TRIBENZALDEHYDE, 95%, 250mg

(3-Methoxypyrazin-2-yl)methanamine hydrochloride, 95+%, 250mg

N-Methyl-1-(4-nitrophenyl)methanamine, 97.0%, 25g

6-ethyl-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 250mg

6-Cyano-7-azaindole, 95.0%, 250mg

3-(2-AMINO-4-PYRIMIDINYL)BENZENECARBONITRILE, 95.0%, 250mg

1-(3-Chlorophenyl)cyclopropanecarbonitrile, 95.0%, 5g